1
Eli Lilly Hit with $220M Verdict—Legal Risks Skyrocket
A $220M verdict rocks Eli Lilly. Supreme Court sides against them in a Medicaid fraud case. First of its kind for Big Pharma. Stock's been on fire—up 57% this year alone. Now, the spotlight's on legal risks. Will this shift the company's trajectory?
Read full story

